pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,928 catalysts · 3,288 8k filing · 1,368 grant · 1,000 device adverse event · 615 approval · 582 earnings · 476 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 118 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-24×clear all
type
  • 8k filing3,288
  • grant1,368
  • device adverse event1,000
  • approval615
  • earnings582
  • device 510k476
device pma
297
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 23, 2026

    50
    ›Feb 24, 2026approval171d agoROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Feb 24, 2026approval171d agoCLOMIPHENE CITRATE — FDA approvalCLOMIPHENE CITRATE

    Sponsor: COSETTE. Form: TABLET. Route: ORAL

    full page →CLOMIPHENE CITRATE →fda approvals ↗
    ›Feb 24, 2026approval171d agoLURASIDONE HYDROCHLORIDE — FDA approvalSumitomo Pharma America Inc

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 24, 2026approval171d agoLURASIDONE HYDROCHLORIDE — FDA approvalSumitomo Pharma America Inc

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 24, 2026approval171d agoMICAFUNGIN SODIUM — FDA approvalMICAFUNGIN SODIUM

    Sponsor: YICHANG HUMANWELL. Form: INJECTABLE. Route: INTRAVENOUS

    full page →MICAFUNGIN SODIUM →fda approvals ↗
    ›Feb 24, 2026approval171d agoFOLLISTIM AQ (FOLLITROPIN ALFA/BETA) — FDA approvalfollitropin beta

    Sponsor: ORGANON USA LLC. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →follitropin beta →fda approvals ↗
    ›Feb 24, 2026approval171d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

    full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗
    ›Feb 24, 2026approval171d agoLIRAGLUTIDE — FDA approvalSaxenda

    Sponsor: BIOCON PHARMA. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →Saxenda →fda approvals ↗
    ›Feb 24, 2026approval171d agoBRAFTOVI (ENCORAFENIB) — FDA approvalencorafenib

    Sponsor: ARRAY BIOPHARMA INC. Form: CAPSULE. Route: ORAL

    full page →encorafenib →fda approvals ↗
    ›Feb 24, 2026approval171d agoBRAFTOVI (ENCORAFENIB) — FDA approvalencorafenib

    Sponsor: ARRAY BIOPHARMA INC. Form: CAPSULE. Route: ORAL

    full page →encorafenib →fda approvals ↗
    ›Feb 24, 2026approval171d agoPREGABALIN — FDA approvalViatris Inc

    Sponsor: FOURRTS LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 24, 2026approval171d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 24, 2026approval171d agoLIRAGLUTIDE — FDA approvalNovo Nordisk Inc

    Sponsor: ORBICULAR. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Feb 24, 2026device 510k171d agoEdwards Lifesciences, LLC — HemoSphere Nano Monitor (HSNANO1) (510k cleared)Edwards Lifesciences Corp

    Product code: DQK. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoExo Imaging — AI Platform 2.2 (AIP002) (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Special

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoPhilips Image Guided Therapy Corporation — IntraSight Plus (510k cleared)

    Product code: IYO. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoIceCure Medical , Ltd. — XSense Cryoablation System with CryoProbes (510k cleared)IceCure Medical Ltd.

    Product code: GEH. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoShenzhen Zhimahuaerkai Technology Co., Ltd. — Electric wheelchair (W1,W3) (510k cleared)

    Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoOsteomni, Inc. — OSTEOMNI SPINAL FIXATION SYSTEM (510k cleared)

    Product code: NKB. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoIntuitive Surgical, Inc. — Universal Seal (5-12 mm) (510k cleared)INTUITIVE SURGICAL INC

    Product code: GCJ. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoOSSIO , Ltd. — OSSIOfiber® Suture Anchor (510k cleared)

    Product code: MAI. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoWingderm Electro-Optics , Ltd. — Diode Laser Therapy Systems (WLA-02) (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoSingle Pass, Inc. — SP Electrocautery Device (SP20) (510k cleared)

    Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoSwift Medical, Inc. — Swift Ray 1 (510k cleared)

    Product code: QJF. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device 510k171d agoMego Afek , Ltd. — NanoPress 760A-BT (760A-BT) (510k cleared)

    Product code: JOW. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 24, 2026device pma171d agoAbbott Molecular, Inc. — Alinity m HR HPV (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MAQ. Advisory committee: MI. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoMedtronic Neuromodulation — InterStim™ Therapy System, Verify™ Evaluation System (SNS Urinary Programming Systems A510, A511, A520, A521) (PMA supplement)

    Supplement type: Real-Time Process. Product code: EZW. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoMedtronic Neuromodulation — InterStim™ Therapy System, Verify™ Evaluation System (SNS Bowel Programming Systems A510, A511, A520, A521) (PMA supplement)

    Supplement type: Real-Time Process. Product code: QON. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoMedtronic Sofamor Danek USA, Inc. — INFUSE Bone Graft (PMA supplement)Medtronic USA Inc

    Supplement type: 30-Day Notice. Product code: MPW. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoMedtronic Sofamor Danek USA, Inc. — INFUSE Bone Graft/Medtronic Interbody Fusion Device (PMA supplement)Medtronic USA Inc

    Supplement type: 30-Day Notice. Product code: NEK. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoMedtronic, Inc. — INFUSE Bone Graft (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NPZ. Advisory committee: DE. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoETHICON, Inc. — ETHIZIA™ Hemostatic Patch (PMA supplement)

    Supplement type: 30-Day Notice. Product code: SGV. Advisory committee: SU. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoEndotronix, Inc. — Cordella Pulmonary Artery Sensor System (CorPASS) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MOM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026device pma171d agoABBOTT MEDICAL — Amplatzer™ Amulet™ Left Atrial Appendage Occluder (Amulet) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NGV. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 24, 2026grant171d agoWASHINGTON UNIVERSITY — Dissecting the Impact of HIV-Induced Immunometabolic Perturbation on Tubercul...

    AI grant. $427,623. PI: George Kyei

    full page →nih reporter ↗
    ›Feb 24, 2026grant171d agoUNIVERSITY OF CONNECTICUT STORRS — Role of Alternate Ribosome Binding in Pathogenesis

    AI grant. $447,604. PI: VICTORIA L ROBINSON

    full page →nih reporter ↗
    ›Feb 24, 2026grant171d agoUNIVERSITY OF VIRGINIA — Pathogenesis of the concentric hypertrophy of the kidney arteriolesUniversity of Virginia

    DK grant. $797,878. PI: ROBERTO Ariel GOMEZ

    full page →nih reporter ↗
    ›Feb 24, 2026grant171d agoUNIVERSITY OF CALIFORNIA SANTA CRUZ — The multifaceted pathways of astrovirus entry and egress

    GM grant. $422,677. PI: Valerie Cortez

    full page →nih reporter ↗
    ›Feb 24, 2026grant171d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Technology knowledge optimization for type 1 diabetes in schools (TeKnO T1D: ...

    NR grant. $472,950. PI: Christine March

    full page →nih reporter ↗
    ›Feb 24, 2026grant171d agoUNIVERSITY OF OREGON — Molecular Mechanisms of Antimicrobial Resistance from Machine Learning Augmen...

    GM grant. $401,285. PI: Dhiman Ray

    full page →nih reporter ↗
    ›Feb 24, 2026grant171d agoUNIVERSITY OF ROCHESTER — Influence of pregnancy and the gut microbiome on methylmercury metabolism and...University of Rochester

    ES grant. $415,613. PI: MATTHEW D RAND

    full page →nih reporter ↗
    ›Feb 24, 2026grant171d agoMAYO CLINIC ROCHESTER — Regulation of target cell survival by TBK1 and IKKeMayo Clinic

    AI grant. $624,521. PI: ADRIAN T TING

    full page →nih reporter ↗
    ›Feb 24, 2026grant171d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Camptothecin analogs as "block and lock" agents for HIVUniversity of California San Diego

    AI grant. $718,637. PI: Nadejda S Beliakova-Bethell

    full page →nih reporter ↗
    ›Feb 25, 2026approval170d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 25, 2026approval170d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ← prev
    page 1 of 159
    next →
    $AVBP30.00-4.64%
    $AVBP30.00-4.64%
    $EW91.33-2.47%
    $BSX51.39-0.07%
    $ICCM0.2280+3.64%
    $BSX51.39-0.07%
    $ISRG401.270.00%
    $VTRS16.28+1.12%
    $MDT90.58-0.20%